Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine in Obese Laparoscopic Surgery
NCT02410590Phase 4Withdrawn
- Sponsor
- Merck & Co.
- Start
- Jul 2015
- Primary completion
- Oct 2016
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Merck & Co.. Planned start Jul 2015; status: withdrawn.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02410590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02410590.